Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Dose-related reduction in bupropion plasma concentrations by ritonavir.

Park J, Vousden M, Brittain C, McConn DJ, Iavarone L, Ascher J, Sutherland SM, Muir KT.

J Clin Pharmacol. 2010 Oct;50(10):1180-7. doi: 10.1177/0091270009359524. Epub 2010 May 19.

PMID:
20484617
2.

Bupropion has no effect on intraocular pressure or other ophthalmologic parameters after single or repeat doses in healthy volunteers.

Ghibellini G, Park J, Brittain CF, Iavarone L, Andorn AC, Levy N, Muir KT.

J Clin Pharmacol. 2009 Apr;49(4):489-95. doi: 10.1177/0091270008330981. No abstract available.

PMID:
19318697
3.

An in vitro mechanistic study to elucidate the desipramine/bupropion clinical drug-drug interaction.

Reese MJ, Wurm RM, Muir KT, Generaux GT, St John-Williams L, McConn DJ.

Drug Metab Dispos. 2008 Jul;36(7):1198-201. doi: 10.1124/dmd.107.020198. Epub 2008 Apr 17.

PMID:
18420781
4.

Bupropion for major depressive disorder: Pharmacokinetic and formulation considerations.

Jefferson JW, Pradko JF, Muir KT.

Clin Ther. 2005 Nov;27(11):1685-95. Review.

PMID:
16368442
5.
6.

Care management in three practices--scope for improvement?

Hamilton BA, Primrose WR, Muir KT.

Health Bull (Edinb). 2000 Sep;58(5):380-4.

PMID:
12813790
7.

In vitro remifentanil metabolism: the effects of whole blood constituents and plasma butyrylcholinesterase.

Davis PJ, Stiller RL, Wilson AS, McGowan FX, Egan TD, Muir KT.

Anesth Analg. 2002 Nov;95(5):1305-7, table of contents.

PMID:
12401616
8.

Pharmacokinetics of remifentanil in anesthetized pediatric patients undergoing elective surgery or diagnostic procedures.

Ross AK, Davis PJ, Dear Gd GL, Ginsberg B, McGowan FX, Stiller RD, Henson LG, Huffman C, Muir KT.

Anesth Analg. 2001 Dec;93(6):1393-401, table of contents.

PMID:
11726413
9.

Influence of arteriovenous sampling on remifentanil pharmacokinetics and pharmacodynamics.

Hermann DJ, Egan TD, Muir KT.

Clin Pharmacol Ther. 1999 May;65(5):511-8.

PMID:
10340916
10.

Metabolism of remifentanil during liver transplantation.

Navapurkar VU, Archer S, Gupta SK, Muir KT, Frazer N, Park GR.

Br J Anaesth. 1998 Dec;81(6):881-6.

11.

Long stay care and the NHS. Multidisciplinary assessment is needed.

Primrose WR, Hamilton BA, Muir KT.

BMJ. 1999 Mar 6;318(7184):668. No abstract available.

12.

The comparative pharmacodynamics of remifentanil and its metabolite, GR90291, in a rat electroencephalographic model.

Cox EH, Langemeijer MW, Gubbens-Stibbe JM, Muir KT, Danhof M.

Anesthesiology. 1999 Feb;90(2):535-44.

PMID:
9952162
13.

Remifentanil pharmacokinetics in obese versus lean patients.

Egan TD, Huizinga B, Gupta SK, Jaarsma RL, Sperry RJ, Yee JB, Muir KT.

Anesthesiology. 1998 Sep;89(3):562-73.

PMID:
9743391
14.

The pharmacokinetics and electroencephalogram response of remifentanil alone and in combination with esmolol in the rat.

Haidar SH, Moreton JE, Liang Z, Hoke JF, Muir KT, Eddington ND.

Pharm Res. 1997 Dec;14(12):1817-23.

PMID:
9453074
15.

Evaluating a possible pharmacokinetic interaction between remifentanil and esmolol in the rat.

Haidar SH, Moreton JE, Liang Z, Hoke JF, Muir KT, Eddington ND.

J Pharm Sci. 1997 Nov;86(11):1278-82.

PMID:
9383740
16.

Pharmacokinetics and pharmacodynamics of remifentanil in persons with renal failure compared with healthy volunteers.

Hoke JF, Shlugman D, Dershwitz M, Michałowski P, Malthouse-Dufore S, Connors PM, Martel D, Rosow CE, Muir KT, Rubin N, Glass PS.

Anesthesiology. 1997 Sep;87(3):533-41.

PMID:
9316957
17.

Comparative pharmacokinetics and pharmacodynamics of remifentanil, its principle metabolite (GR90291) and alfentanil in dogs.

Hoke JF, Cunningham F, James MK, Muir KT, Hoffman WE.

J Pharmacol Exp Ther. 1997 Apr;281(1):226-32.

PMID:
9103501
18.

Remifentanil and pulmonary extraction during and after cardiac anesthesia.

Duthie DJ, Stevens JJ, Doyle AR, Baddoo HH, Gupta SK, Muir KT, Kirkham AJ.

Anesth Analg. 1997 Apr;84(4):740-4.

PMID:
9085949
19.

Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development.

Minto CF, Schnider TW, Egan TD, Youngs E, Lemmens HJ, Gambus PL, Billard V, Hoke JF, Moore KH, Hermann DJ, Muir KT, Mandema JW, Shafer SL.

Anesthesiology. 1997 Jan;86(1):10-23.

PMID:
9009935
20.

Ethanol Pharmacodynamics at Low Blood Concentrations.

Gupta SK, Ellinwood EH, Muir KT, Hege S, Kleoudis C, Powell JR.

Am J Ther. 1996 May;3(5):375-382.

PMID:
11862275
21.

Remifentanil versus alfentanil: comparative pharmacokinetics and pharmacodynamics in healthy adult male volunteers.

Egan TD, Minto CF, Hermann DJ, Barr J, Muir KT, Shafer SL.

Anesthesiology. 1996 Apr;84(4):821-33. Erratum in: Anesthesiology 1996 Sep;85(3):695.

PMID:
8638836
22.

Pharmacokinetics and pharmacodynamics of remifentanil in volunteer subjects with severe liver disease.

Dershwitz M, Hoke JF, Rosow CE, Michałowski P, Connors PM, Muir KT, Dienstag JL.

Anesthesiology. 1996 Apr;84(4):812-20.

PMID:
8638835
23.

Measured context-sensitive half-times of remifentanil and alfentanil.

Kapila A, Glass PS, Jacobs JR, Muir KT, Hermann DJ, Shiraishi M, Howell S, Smith RL.

Anesthesiology. 1995 Nov;83(5):968-75.

PMID:
7486182
24.

Histamine concentrations and hemodynamic responses after remifentanil.

Sebel PS, Hoke JF, Westmoreland C, Hug CC Jr, Muir KT, Szlam F.

Anesth Analg. 1995 May;80(5):990-3.

PMID:
7726445
25.

Pharmacokinetics of remifentanil (GI87084B) and its major metabolite (GI90291) in patients undergoing elective inpatient surgery.

Westmoreland CL, Hoke JF, Sebel PS, Hug CC Jr, Muir KT.

Anesthesiology. 1993 Nov;79(5):893-903.

PMID:
7902033
26.

The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteers.

Egan TD, Lemmens HJ, Fiset P, Hermann DJ, Muir KT, Stanski DR, Shafer SL.

Anesthesiology. 1993 Nov;79(5):881-92.

PMID:
7902032
27.

Remacemide.

Muir KT, Palmer GC.

Epilepsy Res Suppl. 1991;3:147-52. Review. No abstract available.

PMID:
1777071
28.

Effect of food on oral availability of apresoline and controlled release hydralazine in hypertensive patients.

Jackson SH, Shepherd AM, Ludden TM, Jamieson MJ, Woodworth J, Rogers D, Ludden LK, Muir KT.

J Cardiovasc Pharmacol. 1990 Oct;16(4):624-8.

PMID:
1706804
29.

Hydralazine dose-response curve analysis.

Graves DA, Muir KT, Richards W, Steiger BW, Chang I, Patel B.

J Pharmacokinet Biopharm. 1990 Aug;18(4):279-91.

PMID:
2231320
30.

The influence of assay variability on pharmacokinetic parameter estimation.

Graves DA, Locke CS Jr, Muir KT, Miller RP.

J Pharmacokinet Biopharm. 1989 Oct;17(5):571-92.

PMID:
2614686
31.

Analysis of amiodarone and desethylamiodarone in serum and tears by reversed-phase high-performance liquid chromatography.

Muir KT, Kook KA, Stern C, Gardner KM.

J Chromatogr. 1986 Jan 24;374(2):394-9. No abstract available.

PMID:
3958097
32.

Estimation of theophylline clearance during intravenous aminophylline infusions.

Gilman TM, Muir KT, Jung RC, Walberg CB.

J Pharm Sci. 1985 May;74(5):508-14.

PMID:
4020626
33.

High-performance liquid chromatographic method for the determination of labetalol in plasma using ultraviolet detection.

Hidalgo IJ, Muir KT.

J Chromatogr. 1984 Jan 13;305(1):222-7. No abstract available.

PMID:
6707148
34.
35.

Predicting individual phenytoin dosage.

Vozeh S, Muir KT, Sheiner LB, Follath F.

J Pharmacokinet Biopharm. 1981 Apr;9(2):131-46.

PMID:
7277205
36.

Simultaneous determinations by theophylline and its major metabolites in urine by reversed-phase ion-pair high-performance liquid chromatography.

Muir KT, Jonkman JH, Tang DS, Kunitani M, Riegelman S.

J Chromatogr. 1980 Nov 14;221(1):85-95.

PMID:
7451627
37.
38.

Curve fitting and modeling in pharmacokinetics.

Muir KT, Riegelman S.

J Pharmacokinet Biopharm. 1979 Dec;7(6):685-7. No abstract available.

PMID:
529031
40.

Removal of theophylline from the body by haemoperfusion.

Muir KT, Pond SM.

Clin Pharmacokinet. 1979 Jul-Aug;4(4):320-1. No abstract available.

PMID:
487687
41.

Plasma concentration of edrophonium in man.

Calvey TN, Williams NE, Muir KT, Barber HE.

Clin Pharmacol Ther. 1976 Jun;19(6):813-20.

PMID:
1269219
42.

The effect of edrophonium on erythrocyte acetylcholinesterase and neuromuscular function in the rat.

Barber HE, Calvey TN, Muir KT, Taylor K.

Br J Pharmacol. 1976 Jan;56(1):93-9.

44.

Supplemental Content

Support Center